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The objectives of this study were to determine the effects
of low flow oxygen and isosorbide dinitrate on rest and
exercise biventricular ejection fractions in patients with
chronic obstructive pulmonary disease and to relate these
ejection fraction responses to changes in pressure and
flow.Nine patients with stable, moderate to severechronic
obstructive pulmonary disease who had no prior history
of heart failure performed supine exercise with simul-
taneous hemodynamic and radionuclide ventriculo-
graphic monitoring. Eight patients performed a second
exercise during low flow oxygen breathing and five per-
formed a third exercise after ingesting 10 mg oral iso-
sorbide. Oxygen led to a decrease in exercise pulmonary
artery pressure in all subjects and a decline in total
pulmonary resistance in fiveof the seven in whom it was
measured. Right ventricular ejection fraction increased
Hypoxic vasoconstncuon can produce elevation of pul-
monary artery pressure, which in turn can lead to right
ventricularhypertrophy,dilationand failure (1-3). Low flow
oxygen therapy is effective in lowering pulmonary artery
pressure in many patients with chronic obstructive pulmo-
nary disease, but it is expensive, inconvenient, potentially
toxic and ineffective in some patients (4-11). The hemo-
dynamic responses to low /lowoxygen cannot be accurately
predictedfrommeasurementsofarterialoxygentension(POl)
(8). Therefore, direct hemodynamic measures are required
to assess the response of the pulmonary vasculature to ox-
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0.05 or more only in subjects who had a decrease in total
pulmonary resistance. Isosorbide led to an increase in
rest and exercise right and left ventricular ejection frac-
tions with simultaneous decreases in pulmonary artery
pressure, total pulmonary resistance, blood pressure and
arterial oxygen tension.
These results suggest that in patients with chronic
obstructive pulmonary disease but without a history of
right heart failure, the right ventricular systolic func-
tional response to low flow oxygen and isosorbide at rest
and exercise is, in part, determined by changes in total
pulmonary resistance. The chronic relation between right
ventricular ejection fraction and pulmonary hemody-
namics in patients with chronic obstructive pulmonary
disease remains to be evaluated .
ygen therapy, Similarly, it has been shown that a number
of vasodilators are also effective in lowering pulmonary
artery pressure in patients with chronic obstructive pul-
monary disease (12-15). Among these vasodilators, oral
nitrates are used frequently for concomitant ischemic car-
diovascular disease (12-14).
We recently developed and validated a method of gated
blood pool radionuclide ventriculographic measurement of
right ventricular ejection fraction (16,17) . The blood pool
study can also be analyzed for left ventricular ejection frac-
tion, In rest studies, it has been shown that the right ven-
tricular ejection fraction is related inversely to pulmonary
artery pressure (18-20) . This relation is complicated by a
number of other factors, such as the presence of right ven-
tricular infarction, tricuspid regurgitation or severe left ven-
tricular dysfunction (20) . In normal subjects, exercise right
ventricular ejection fraction appears to be inversely related
to total pulmonary resistance (17),
The current study sought to: I) test the effect of low flow
oxygen and isosorbide on rest and exercise right and left
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ventricular ejection fractions in patients with chronic ob-
structive pulmonary disease, and 2) compare the ejection
fractions with simultaneous measures of pressure and flow.
Methods
Study patients. Nine patients with stable, moderate to
severechronic obstructive pulmonary diseaseand no history
of heart failure were studied. Ages, pulmonary function
data, medications and electrocardiographic data from the
nine patients are listed in Table I. All patients had a forced
expiratory volume in I second of less than 65% of the
predicted value, a forced expiratory volume/forced vital ca-
pacity ratio of less than 70% and a total lung capacity greater
than 75% of predicted (21,22). All patients were smokers
and all had a chronic cough.
No patient had evidence of primaryleft heart abnormality
by history, physical examination, 12 lead electrocardiogram
or chest X-ray fi lm. No patient had a prior history of heart
failure. Because of the difficulty in separating right heart
failure in cor pulmonale from right heart failure secondary
to left heart failure on clinical grounds (23,24), this exclu-
sion eliminated all patients with cor pulmonale. Because
patients served as their own controls, they were maintained
on their stable medications. Informed consent was obtained
from all patients using forms approved by the University of
Washington Human Subjects Committee.
Hemodynamic measurements. Before the actual test-
ing, all subjects performed an exercise test to fami liarize
themselves with the equipment. On the day of the test,
subjects refrained from drinking coffee or tea or smoking
Table 1. Clinical and Pulmonary Function Data in Nine Patients
cigarettes. A triple lumen thermodilution Swan-Ganz cath-
eter was introduced from the basilic vein to the right pul-
monary artery. A plastic catheter was placed percutaneously
in the radial artery. The patient was then transported to the
nuclear imaging suite for exercise testing. Patients per-
formed graded exercise using a supine bicycle ergometer
(Quinton Instruments) .
All subjects had a rest baselin e and graded exercise study
during room air breathing. After 30 minutes' rest, repeat
baseline studies were obtained and all subjects were given
oxygen at 4 liters/min via nasal prongs for 30 minutes. A
post-oxygen rest study was obtained and subjects performed
a second graded exercise while breathing oxygen; one sub-
ject could not perform a second exercise. Oxygen admin-
istration was discontinued and the subjects then rested for
30 minutes; fi ve agreed to ingest a 10 mg isosorbide dinitrate
tablet and perform a third exercise. Thirty minutes after
ingestion, a repeat rest study and a third graded exercise
were performed. For each exercise, subjects began pedaling
at 200 kilopond-meters (kpm)/min and increased 200 kpml
minforeach4 minutestage untilsymptom-limited maximum
was reached. This is the same exercise protocol by which
normal volunteers have been studied (17).
Twelve lead electrocardiograms were obtained during
each baseline period and during each stage of exercise.
Arterial blood pressure, pulmonary artery pressure, pul-
monary wedge pressure and central venous pressure mea-
surements were made at each baseline and during the last
2 minutes of each stage of exercise using Ailtech MS-20AA
15FA strain gauges and an Electronics for Medicine VR 8
recorder. Zero reference was midthorax and electrical mean
Rest Artena l
Age FEVI (hters. FEY,/FYC
Blood Gases (mm Hg)
Case (yr) Medica uons % predicted) ( ~) PO, Peo, pH ECG
1* 56 None 192;62 57 75 33 744 Early repol
2 56 Isoproterenol; I 38,46 50 59 40 739 PRWP
medihaler
3 6 1 Armnophyllme I 26,47 41 68 40 7.44 NSST
4 60 Armnophyllme I 39:46 5 1 54 43 7.42 P pulmonale,
PRWP
5 59 Armnophylhne 2 02:65 62 68 37 7 39 Normal
6 63 Isoproterenol: I 89;64 61 87 34 742 Normal
medihaler
7 6 1 Aminophylline, o77:29 42 74 46 739 P pulmonale,
Isoproterenol, PRWP
medihaler
8 63 Aminophylline 074;33 39 66 4 1 749 P pulmonale,
RBBB
9 6 1 Isoproterenol; 1.51 ;50 38 72 40 7 42 PRWP
medihaler
*Thls patient had a normal coronary arteriogram, contrast ventnculogram and cxercrse/redistrbution thallium study I year before this study.
ECG = electrocardiogram: FEYI = forced expiratory volume in 1second: FYC = forced viral capacity, NSST = nonspecificST-Twave abnormalities;
Pee, = partial pressure of carbon dioxide; POl = partial pressure of oxygen, PRPW = poor R wave progression: RBBB = right bundle branch block;
repol = repolarization.
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Figure 1. Right ventricular ejection fraction (RVEF) at rest (A)
and during exercise (B) before and after low flow oxygen (4 liters/
min).
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were determined by the zero point of the two-dimensional
second derivative with respect to time. The computer used
this box and thresholds to draw a separate ventricular region
for each frame. The operator viewed these regions and de-
termined whether to accept or alter them. It was seldom
necessary to alter any of the left ventricular regions, but it
was frequently necessary to alter right ventricular systolic
frames as in the right ventricular validation study (16). The
most frequent alteration was removal of atrial pixels in the
upper left quadrant. The computer-selected left ventricular
background, expressed as counts per pixel, was subtracted
from each frame. With use of the respective regions of
interest, background-corrected time-activity curves were ob-
tained for both the right and left ventricles.
The ejection fractions were calculated from the formula:
ejection fraction = stroke counts/end-diastolic counts, where
end-diastolic counts = the peak of the time activity curve,
usually the first frame, end-systolic counts = the trough
and stroke counts = end-diastolic counts - end-systolic
counts. When blood pool studies are processed in this man-
ner, the right ventricular ejection fraction is highly repro-
ducible and there is a strong correlation between blood pool
and gated first pass right ventricular ejection fraction (n = 22;
correlation coefficient [r] =0.93; y=0.03 +0.89x; stan-
dard error of the estimate = 0.04) and the left and right
ventricular stroke counts are in close agreement (n = 19;
r=0.86; Y=73 + 0.089x; SEE= 116 counts on 300 K
images) (16). The left ventricular ejection fraction obtained
by this method correlates well with both contrast angiog-
raphy (n=32; r=0.82; Y =0.15 +0.66x and gated first
pass studies (n=41; r=0.96; Y =0.00 + 1.01x) (unpub-
lished data).
Statistical analysis. From the ejection fraction and
hemodynamic data, mean and standard deviation were cal-
culated for rest and each exercise stage. Paired t tests were
pressures averaged over at least three respiratory cycles were
recorded.
Radial artery samples were obtained at each baseline and
during the last 2 minutes of each exercise stage for blood
gas measurements which were performed with standard
electrodes.
Thermodilution cardiac output measurements were per-
formed in triplicate during each baseline period and once
during each exercise period. For the baseline period, the
mean of the three measures is reported.
Total pulmonary resistance was calculated by the for-
mula: total pulmonary resistance [dynes-s-cmr '] = (mean
pulmonary artery pressure [mm Hg] x 80)/COTD; where
COTD is the thermodilution cardiac output in liters/min.
Systemic resistance was calculated by the formula: Systemic
resistance [dynes-s-cm -5] = (mean blood pressure [mm
Hg] x 80)/COTD liters/min.
Radionucdde imaging measurements. Ten milliliters
of venous blood was withdrawn and the red blood cells
labeled in vitro with 30 mCi of technetium-99m (25). The
labeled red blood cells were then reinjected and allowed to
equilibrate before imaging. Imaging was performed using
a low energy, high sensitivity, parallel-hole collimator and
an Ohio Nuclear series 100 gamma scintillation camera in-
terfaced with a dedicated computer system (Modumed Med-
ical Data Systems, Medtronic). Count and image acquisition
occurred under electrocardiographic control such that cor-
responding 40 ms segments of each cardiac cycle were
screened and stored in the computer core memory; all pa-
tients were in sinus rhythm. Images were obtained as 64 x
64 matrixes. Commercially available software (MDS:MUGX)
was used for acquisition. Studies were acquired in the left
anterior oblique view which provided best ventricular
separation.
During the first baseline rest study, a count targeted
(300 K) and 2 x 2 minute acquisitions were obtained.
Thereafter, a 2 minute acquisition during the last 2 minutes
of exetcise and for each baseline period was acquired. The
first baseline ejection fractions reported are the mean of the
300 K and 2 x 2 minute acquisitions.
The images were converted from the MDS-Modumed
computer system in which they were acquired onto MDS-
A2 software for analysis in Tucson. Before quantitative anal-
ysis, all images were viewed in cine mode. The same com-
puter-selected variable region of interest method, using
commercially available software (MDS-A2:ejection frac-
tion), was applied to both left and right ventricular quan-
titative analysis. This method has been described in detail
for the right ventricle in the validation study from this lab-
oratory (16).
Briefly, a box was placed around the ventricle on the
first frame or image. The operator set thresholds for each of
four quadrants around the box so that a continuous line was
drawn around the ventricle on this image. The thresholds
lACC Vol 2, No 4
October 1983 652-60
MORRISON ET AL
ACUTE INTERVENTIONS IN PULMONARY DISEASE
655
OL.--+---:!:-------+----J
1.0 Room Air Oxygen
0,8 ~.~ ,~~0,6
u.. o-
w
>
...J
0.4 <. .i->:
0,2
A= Rest
B = Exercise
0 I I I
A B A B
1.0
0.8
u.. 0.6
w
>a:
0.4
0.2
Room Air lsordil
A = Rest
B = Exercise
Figure 2. Left ventricular ejection fraction (LVEFj at rest (A)
an.d during exercise (B) before and after low flow oxygen (4 liters/
min).
u~ed to de~ennine if changes with interventions were sig-
nificant, with a probability (p) value less than 0,05 consid-
ered significant.
Results*
Methodology. There was an excellent correlation be-
tween radionuclide left and right ventricular stroke counts
(LYSC, RYSC) during room air breathing (n = 55 rest and
exercise blood pool studies from the nine subjects; r = 0.98;
RYSC = - 246 + 1.01 LYSC); during oxygen breathing
(n = 60 rest and exercise blood pool studies from eight sub-
jects; r=0.93; RYSC= -143 + 1.00 LYSC); and after
isosorbide ingestion (n = 38 rest and exercise blood pool
studies from five subjects; r=0.95; RVSC= +71 + 0.96
LYSC).
Right and left ventricular ejection fractions. Room air
versus oxygen breathing Figure I shows rest and maximal
exercise right ventricular ejection fractions during room air
and oxygen breathing for all eight subjects who performed
both exercises. The rest and exercise ejection fractions were
not significantly different with oxygen, although there was
a trend toward a greater increase in exercise ejection fraction
during oxygen breathing.
Figure 2 shows rest and exercise left ventricular ejection
fractions during room air and oxygen breathing, The ejection
fractions were not significantly different with oxygen, al-
though there was a trend toward increased ejection fraction
during oxygen breathing.
lsosorbide dinitrate ingestion. Figure 3 shows the rest
and exercise right ventricular ejection fractions during base-
line and after isosorbide ingestion for the five subjects who
*Tables listing ejection fraction and hemodynamic values for each
patient are available from the authors on request
Figure 3. Right ventncular ejection fraction (RVEF) at rest (A)
and exercise (B) before and after 10 mg oral isosorbide dinitrate
(lsordil) .
p~rformed b?th exe~cises. The rest values were significantly
higher after isosorbide (p < 0.01), but the maximal exercise
values were not. No patient's right ventricular ejection frac-
tion fell with exercise after isosorbide, in contrast to the
baseline exercise value.
Figure 4 shows the rest and exercise left ventricular ejec-
tion fractions before and after isosorbide ingestion. The rest
values were significantly higher after isosorbide (p < 0.01)
but the exercise values were not. However, all patients
demonstrated an increase in left ventricular ejection fraction
with exercise after isosorbide.
Hemodynamic data and ejection fractions. Figures 5
and 6 show the mean ± standard deviation of the radio-
nuclide and hemodynamic variables during rest and at each
exercise level during room air breathing, oxygen breathing
and after isosorbide ingestion.
The right ventricular ejection fraction did not increase
significantly with exercise during any of the test conditions.
At each stage, it was slightly higher during oxygen breathing
and after isosorbide , but the only difference that reached
statistical significance was stage I isosorbide versus baseline
(p < 0.05).
The total pulmonary resistance did not decrease normallv
with exercise under any of the conditions of testing (17). it
was lower during the oxygen and isosorbide exercises, hut
the only differences that achieved statistical significance
were stage I oxygen (p < 0.05) and stage II isosorbide (p
< 0.05 values.
The pulmonary artery pressure increased abnormally
during baseline exercise (17). Exercise pulmonary artery
pressure was lower with oxygen and after isosorbide, with
stage I oxygen (p < 0.05) and both rest and all exercise
stages after isosorbide (rest p < 0.01, stage I p < 0.01,
stage II p < 0.00 I) reaching statistical significance.
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Figure 4. Left ventricular ejection fraction (LVEF) at rest (A)
and during exercise (B) before and after 10 mg oral isosorbide
dinitrate (Isordil).
rest or exercise left ventricular ejection fraction values. Iso-
sorbide led to significant increases in rest (p < 0.01) and
stage 1 exercise (p < 0.05) left ventricular ejection fraction
values.
The blood pressure increased with exercise under all
conditions. Oxygen breathing did not lead to a significant
difference in rest or exercise blood pressure. Isosorbide led
to lower blood pressure at rest (p < 0.05) and during both
exercise stages (stage 1 p < 0.01, stage II p < 0.001).
Although the exercise was performed supine, significant
increases in stroke volume occurred under all conditions.
There was no significant difference in stroke volume at rest
or during exercise with oxygen. There was a fall in rest
stroke volume after isosorbide (p < 0.05) but exercise stroke
volume was not significantly different from the baseline
value.
The heart rate increased with exercise under all condi-
tions. Rest heart rate was higher (p < 0.05) after isosorbide.
Rest and exercise heart rate during oxygen breathing and
exercise heart rate after isosorbide ingestion were not dif-
ferent from the baseline value.
The arterial oxygen tension (PaOz) fell during baseline
exercise. With oxygen breathing, the PaOz was higher at
rest (p < 0.05) and during each exercise stage. The PaOz
was not significantly different after isosorbide ingestion.
The left ventricular ejection fraction did not increase
significantly with baseline exercise. Oxygen did not change
Discussion
Relation between pulmonary artery pressure and re-
sistance and right ventricular ejection fraction. Recent
studies (18) of patients with chronic obstructive pulmonary
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disease have noted a significant inverse relation between
rest pulmonary artery pressure and right ventricular ejection
fraction. This type of relation has also been noted in a group
of patients with cardiac conditions that excluded intracardiac
shunts (19). Other studies were unable to demonstrate a
significant relation between the pulmonary artery pressure
and right ventricular ejection fraction at rest in patients with
chronic obstructive pulmonary disease (26), coronary artery
disease (27) or aortic or mitral valve disease (28). A rest
and exercise study of normal volunteers from our labora-
tories demonstrated a significant relation between total pul-
monary resistance and right ventricular ejection fraction,
but no significant relation was found between pulmonary
artery pressure and right ventricular ejection fraction (17).
The reasons for discrepancies between studies like these
are germane to the attempt, in this study, to relate rest and
exercise right ventricular function to simultaneously mea-
sured hemodynamic variables. Our view is that right ven-
tricular systolic function is afterload dependent and pul-
monary artery pressure and total pulmonary resistance are
components or indexes of afterload but neither of these
measures is the sole determinant of right ventricular after-
load and afterload is not the sole determinant of right ven-
tricular systolic function (20). In an analysis of right ven-
tricular function in a heterogeneous group of cardiopul-
monary conditions, we noted the roles of: I) tricuspid re-
gurgitation as an afterload factor, 2) right ventricular ischemia
or infarction as inferred from right coronary artery lesions
and inferior left ventricular wall motion abnormalities, and
3) marked reduction of left ventricular systolic function (20).
Role of coronary artery disease. The initial objectives
of this study of patients with chronic obstructive pulmonary
disease included looking at the effects of multiple interven-
tions on cardiac performance in pure pulmonary disease.
For that reason, a rigorous attempt was made to exclude
patients with any clinical suggestion of primary cardiac dis-
ease. Despite the absence of clinical or rest and exercise
electrocardiographic evidence of coronary artery disease,
one patient had a rest and exercise wall motion abnormality
strongly suggesting coronary disease. Patients with this de-
gree of lung disease will stop exercising because of dyspnea
long before maximal heart rates are achieved (29). For this
reason, neither exercise thallium nor exercise ventriculog-
raphy is nearly as sensitive or specific in screening for coro-
nary artery disease in patients with chronic lung disease as
III other patient groups. The implication is that coronary
artery disease cannot be reasonably excluded in patients with
lung disease without coronary angiography. As suggested
previously, coronary disease, especially right coronary dis-
ease with concomitant right ventricular infarction or mul-
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tiple vessel disease with rest or exercise reduction in global
left ventricular function, could be expected to significantly
alter the relations between ejection fractions and hemody-
namics (20).
Role of right heart failure. An additional consequence
of attempting to exclude primary cardiac disease occurred
as a result of excluding patients with a history of biventri-
cular congestive heart failure who were receiving digitalis,
diuretic drugs or medication for afterload reduction. Be-
cause of the diffi culty in clinically separating right heart
failure secondary to chronic obstructive pulmonary disease
from right heart failure secondary to left heart failure (23,24),
it is likely that some patients with only cor pulmonale were
excluded. The result is that only one of the nine subjects
had a pulmonary artery mean pressure at rest greater than
20 mm Hg. Accordingly, this study examines a narrow range
of rest pulmonary artery pressures. It is true that most pa-
tients with chronic obstructive pulmonary disease have only
mild elevations of pulmonary artery pressure at rest, which
is the reason that exercise is frequently necessary to see
hemodynamic changes with oxygen (8). On the other hand,
it is likely that the inclusion of patients with clinical right
heart failure would have produced a far wider range of
hemodynamic data.
Effect of medications . Another important complicating
influence is the effect of medications. Both aminophylline
and beta-agonist medications have been reported to increase
ejection fractions in some patients with chronic lung disease
(30,31). When this study was begun, consideration was
given to withholding patients' medications. An example of
the problems that can occur with this approach is summa-
rized: One patient, with an FEYI =0.7 liter/min was asked
to discontinue aminophylline for 24 hours; he reported to
the catheterization laboratory dyspneic at rest, audibly
wheezing, with 25 mm Hg of pulsus paradoxus. After an
intravenous loading dose of aminophylline, he improved
symptomatically and had 6 mm Hg of pulsus paradoxus.
He was subsequently able to perform the test. Recognizing
the effects of these medications emphasizes the importance
of comparing each patient with himself. It also provides an
additional source of error in pooled data. Thus, the attempt
to discontinue medications for study purposes is medically
dangerous and at the same time changes the patient from
the setting to which one would ultimately like to apply the
study results.
Potential errors in measurement. All of the primary
measurements used in this study (vascular pressures, cardiac
output, right ventricular ejection fraction and left ventricular
ejection fraction) are subject to large potential errors, es-
pecially at exercise in patients with chronicobstructive pul-
monary disease (32-34) . Withexercise, all of these subjects
developed greater than 10 mrn pulsus paradoxus in their
blood pressure recordings and all had greater than 10 mm
Hg respiratory variations in central venous pressure, pul-
monary artery systolic pressure and pulmonary wedge pres-
sure. Because intrapleural pressure is not necessarily uni-
formand because intraesophageal pressure does not necessarily
reflect intrapleural pressure, especially in a supine subject,
there is no well established way to "correct" these pressures
or average their variations (32,33) . For this study, the elec-
trical mean pressure averaged over three respiratory cycles
was used. This type of problem must be taken into account
when attempting to determine the significance of relations
between " measured" pressures and other variables, such
as resistance, calculated from these pressures.
The large intrathoracic pressure variations raise the pos-
sibility that flow may also be uneven. If this were the case,
flow measured over a period that is short relative to respi-
ration might be different from fl ow measurements averaged
over time. Additional potential sources of problems with
the thermodilution method include the development of sub-
clinical pulmonary regurgitation or tricuspid regurgitation
or opening of a foramen ovaIe-all of which can occur with
patients withpulmonary hypertension expeciallyat exercise.
The correlation of left and right ventricular stroke counts
suggests that significant regurgitation or shunting did not
occur in these subjects.
Methodologic factors. Considerable controversy has at-
tended the efforts to derive rightventricular ejection fraction
measurements from gated blood pool radionuclide ventric-
ulography (34) . The method used in this study has been
validated in rest studies that included patients with abnormal
right heart hemodynamics and function (1 6). As stated in
the methods paper (1 6). although the computer edge detec-
tion programs are used to initially select regions of interest.
it is frequently necessary for the operator to alter these
regions, especially the frames from ventricular systole. As
the degree of right heart abnormality increases, particularly
with right heart dilation, the intervention becomes more
frequent and more difficult. This problem does not occur
with analysis of the left ventricle. Thus, the correspondence
of left and right ventricular stroke counts strongly supports
the validity of the measurements made in this study. Clearly,
the presence of signifi cant tricuspid or pulmonary regurgi-
tation would make it impossible to use these "standards."
These data continue to support the feasibility of such mea-
sures in patients with severe abnormality at exercise as well
as at rest.
In light of the significant complicating features cited, it
is not surprising that disparate results have been obtained
when the right ventricular ejection fraction has been com-
pared with hemodynamic measures in patients with chronic
lung disease ( 18,26). An awareness of these factors provides
insight into the seemingly contradictory results that can ac-
crue from pooling the results from many patients. For ex-
ample, in this study, low fl ow oxygen appears to decrease
pulmonary resistance at stage I exercise but to have no effect
at stage II. This is clearly because it is the sickest patients
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who have the greatest response to oxygen and who could
only complete one stage of exercise. In addition, sicker
patients, that is, patients with worse obstruction of airways,
also had greater intrathoracic pressure variations, thereby
compounding the difficulties of measuring pressure and flow,
It is possible that some of the changes that appear only
as trends in this study might reach statistical significance
were there more patients; examples include exercise ejection
fractions before and after oxygen, At the same time, inclu-
sion of patients with right heart failure, patients with left
heart disease and those taking different medications could
alter the data In a variety of ways,
Clinical implications. It might be concluded from a study
such as this that the attempt to exclude the effects of con-
comitant heart diseases and drugs and accurately measure
and relate the rest and exercise ejection fractions and hemo-
dynamic variables in patients with chronic obstructive pul-
monary disease is a practical impossibility, It is our con-
clusion that such an attempt is necessary if we are to answer
such basic questions as, What is the role of oxygen therapy
in chronic obstructive pulmonary disease? Or, What is the
effect of vasodilators on hemodynamics in chronic obstruc-
tive pulmonary disease? In addition, attempts to "simplify"
the endeavor by turning to animal models have frequently
so distorted the problem as to obfuscate rather than clarify,
This study is a preliminary attempt to answer these questions
and an even more preliminary endeavor to establish a basic
methodology for evaluating mechanisms of heart and lung
dyspnea, With regard to the former it says simply: low flow
oxygen can lead to improved right and left ventricular ejec-
tion fractions in some patients with chronic obstructive pul-
monary disease, It appears to do this most frequently during
exercise and seems related to decreases in pulmonary pres-
sure or resistance, but might also favorably affect left and
right ventricular ischemia, thereby improving contractile
function, Isosorbide dinitrate can lower filling and afterload
pressures at rest and during exercise in patients with lung
disease and may improve ejection fraction, These improve-
ments may be accompanied by significant decreases in car-
diac output and arterial oxygen tension at rest in a given
patient.
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